WELL Health Technologies (TSE:WELL) Given New C$7.50 Price Target at Royal Bank of Canada

WELL Health Technologies (TSE:WELL) had its price objective cut by investment analysts at Royal Bank of Canada from C$8.50 to C$7.50 in a report released on Monday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective indicates a potential upside of 84.28% from the stock’s current price.

A number of other analysts have also commented on WELL. CIBC raised their price target on WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday, December 13th. Ventum Financial increased their target price on WELL Health Technologies from C$7.50 to C$8.00 in a research note on Thursday, January 30th. Scotiabank raised their price target on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research report on Monday, December 16th. Raymond James lifted their target price on shares of WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. Finally, Haywood Securities increased their price objective on shares of WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th.

WELL Health Technologies Price Performance

WELL Health Technologies stock traded down C$0.90 during midday trading on Monday, hitting C$4.07. 5,710,509 shares of the company’s stock were exchanged, compared to its average volume of 897,036. WELL Health Technologies has a 52-week low of C$3.41 and a 52-week high of C$7.36. The stock has a 50-day moving average price of C$5.81 and a two-hundred day moving average price of C$5.58. The company has a market cap of C$1.02 billion, a P/E ratio of 13.79, a PEG ratio of -1.93 and a beta of 1.20. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.